Trial Information

A Prospective Study of Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy With or Without Mediastinal Irradiation

- The tests and procedures in this study are part of regular cancer care but this study
offers more structured timing of these standard tests.

- Due to the potential lung toxicity associated with bleomycin-based chemotherapy,
pulmonary function tests are routinely performed. Pulmonary function tests will be
performed by a licensed, registered respiratory therapist and performed prior to the
beginning of treatment, between the chemotherapy and radiation therapy (only for
patients receiving both chemotherapy and radiation therapy), and at approximately 1
month, 6 months, 1 year and 2 years after the completion of all treatments.

- A CAT scan will be performed prior to the beginning of treatment, and approximately 1
month, 6 months, 1 year and 2 years after the completion of all treatments.

- A self-administered questionnaire will be performed on the days the patient is
undergoing pulmonary function tests.